TGFB1 and pulmonary fibrosis: We have observed that pBPB treatment reduces pulmonary inflammation, extracellular matrix deposition (collagen) and TGF-β in bleomycin-treated mice (Figure 8, Supplementary Figure S10 and S11), which indicates the possible therapeutic role for pBPB in pulmonary fibrosis.